Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / BFRI - Celyad Oncology Longeveron leads healthcare gainers; Esperion Therapeutics Biofrontera among major losers

BFRI - Celyad Oncology Longeveron leads healthcare gainers; Esperion Therapeutics Biofrontera among major losers

Biofrontera Inc.
Gainers: Celyad Oncology CYAD +41%, Longeveron LGVN +28%, Petros Pharmaceuticals (NASDAQ:PTPI) +26%, AirSculpt Technologies AIRS +12%, Werewolf Therapeutics (NASDAQ:HOWL) +12%. Losers: Esperion Therapeutics ESPR -40%, Biofrontera (NASDAQ:BFRI) -17%, Ginkgo Bioworks (NYSE:DNA) -16%, Valneva SE VALN -16%, Aesthetic Medical (NASDAQ:AIH) -14%.

For further details see:

Celyad Oncology, Longeveron leads healthcare gainers; Esperion Therapeutics, Biofrontera among major losers
Stock Information
Company Name: Biofrontera Inc.
Stock Symbol: BFRI
Market: NASDAQ
Website: biofrontera-us.com
Menu
BFRI BFRI Quote BFRI Short BFRI News BFRI Articles BFRI Message Board
Get BFRI Alerts

News, Short Squeeze, Breakout and More Instantly...